Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: August 31, 2006
Context: The filing discloses the posting of additional supplemental information on the company's website regarding net sales, months on hand, and estimated demand for key products and growth drivers.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references the existence of data for the following periods and segments but does not list the figures within the report body:
- Segments: International Pharmaceutical, Nutritionals, and Other Health Care.
- Data Points Referenced: Net sales, months on hand, and estimated demand.
- Periods Covered: As of June 30, 2006; March 31, 2006; June 30, 2005; and March 31, 2005.
Material Changes
The filing does not describe specific material changes in financial performance or operations. The primary event reported is the availability of updated supplemental data on the company's website.
Guidance, Outlook, and Risks
Management Commentary: The company states that the supplemental information is furnished and incorporated by reference as Exhibit 99.1.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in this filing text.
Guidance: No forward-looking guidance is provided in this specific document.
Investor Verification Checklist
- Verify the specific net sales and demand figures by accessing Exhibit 99.1 on the company's website (www.bms.com) as referenced in the filing.
- Compare the "months on hand" data for key products between the June 30, 2006, and June 30, 2005, periods to assess inventory trends.
- Confirm the breakdown of growth drivers within the International Pharmaceutical, Nutritionals, and Other Health Care segments.